Nuclear UDP-glucuronosyltransferases: Identification of UGT2B7 and UGT1A6 in human liver nuclear membranes

被引:28
|
作者
Radominska-Pandya, A
Pokrovskaya, ID
Little, JM
Jude, AR
Kurten, RC
Czernik, PJ
机构
[1] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Dept Physiol, Little Rock, AR 72205 USA
[3] Univ Arkansas, Dept Chem, Little Rock, AR USA
关键词
glucuronosyltransferase; human; liver; nucleus; nuclear membrane; glueuronide;
D O I
10.1006/abbi.2001.2743
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have demonstrated the subcellular localization of the human UDP-glucuronosyltransferases (UGTs), UGT2B7 and UGT1A6, in endoplasmic reticulum. (ER) and nuclear membrane from human hepatocytes and cell lines, by in situ immunostaining and Western blot. Double immunostaining for UGT2B7 and calnexin, an ER resident protein, showed that UGT2B7 was equally present in ER and nuclear membrane whereas calnexin was present almost exclusively in ER. Immunogold labeling of HK293 cells expressing UGT2B7 established the presence of UGT2B7 in both nuclear membranes. Enzymatic assays with UGT2B7 substrates confirmed the presence of functional UGT2B7 protein in ER, whole nuclei, and both outer and inner nuclear membranes. This study has identified, for the first time, the presence of UGT2B7 and UGT1A6 in the nucleus and of UGT2B7 in the inner and outer nuclear membranes. This localization may play an important functional role within nuclei: protection from toxic compounds and/or control of steady-state concentrations of nuclear receptor ligands. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:37 / 48
页数:12
相关论文
共 50 条
  • [21] Effect of UGT1A6 and UGT2B7 polymorphisms on the valproic acid serum concentration and drug-induced liver injury
    Yu, Mengchen
    Zhao, Yan
    Zhou, Fan
    Li, Weiliang
    Liu, Jing
    Zhao, Linlin
    Song, Zhirui
    Tong, Ling
    Zhang, Ying
    Wang, Yajuan
    Shang, Shenglan
    Yu, Airong
    PHARMACOGENOMICS, 2024, 25 (12-13) : 527 - 538
  • [22] Differences in the regulation of the UGT1A1, UGT1A6, UGT2B4 and UGT2B7 genes in human liver and small intestine define tissue specific and interindividual glucuronidation activities.
    Strassburg, CP
    Kneip, S
    Topp, J
    Obermayer-Straub, P
    Turkey, RH
    Manns, MP
    HEPATOLOGY, 2000, 32 (04) : 330A - 330A
  • [23] THE EXPRESSION OF UDP-GLUCURONOSYLTRANSFERASES OF THE UGT1 FAMILY IN HUMAN LIVER AND KIDNEY AND IN RESPONSE TO DRUGS
    SUTHERLAND, L
    EBNER, T
    BURCHELL, B
    BIOCHEMICAL PHARMACOLOGY, 1993, 45 (02) : 295 - 301
  • [24] Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3
    Huang, YH
    Galijatovic, A
    Nguyen, N
    Geske, D
    Beaton, D
    Green, J
    Green, M
    Peters, WH
    Tukey, RH
    PHARMACOGENETICS, 2002, 12 (04): : 287 - 297
  • [25] SUBSTRATE SPECIFICITIES OF 2 STABLY EXPRESSED HUMAN LIVER UDP-GLUCURONOSYLTRANSFERASES OF THE UGT1 GENE FAMILY
    EBNER, T
    BURCHELL, B
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (01) : 50 - 55
  • [26] Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes
    Peterkin, Vincent C.
    Bauman, Jonathan N.
    Goosen, Theunis C.
    Menning, Lee
    Man, Michael Z.
    Paulauskis, Joseph D.
    Williams, J. Andrew
    Myrand, Scott P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (04) : 458 - 468
  • [27] Cooperation between two PAH-inducible UDP-glucuronosyltransferases (UGT1A6 and UGT1A7) in the formation of benzo[a]pyrene-3,6-diphenol diglucuronide
    Raschko, FT
    Gschaidmeier, HM
    Seidel, A
    Oesch, F
    Burchell, B
    Ritter, JK
    Bock, KW
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R135 - R135
  • [28] Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liver.
    Mirkov, S.
    Ramirez, J.
    Zhang, W.
    Chen, P.
    Das, S.
    Liu, W.
    Ratain, M. J.
    Innocenti, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S61 - S61
  • [29] Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma
    Matsumoto, Jun
    Nishimoto, Anzu
    Watari, Shogo
    Ueki, Hideo
    Shiromizu, Shoya
    Iwata, Naohiro
    Takeda, Tatsuaki
    Ushio, Soichiro
    Kajizono, Makoto
    Fujiyoshi, Masachika
    Koyama, Toshihiro
    Araki, Motoo
    Wada, Koichiro
    Zamami, Yoshito
    Nasu, Yasutomo
    Ariyoshi, Noritaka
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2023, 478 (08) : 1779 - 1790
  • [30] Analysis of substrate specificities and tissue expression of rat UDP-glucuronosyltransferases UGT1A7 and UGT1A8
    Webb, LJ
    Miles, KK
    Auyeung, DJ
    Kessler, FK
    Ritter, JK
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (01) : 77 - 82